Margaret C Fang

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008
    Margaret C Fang
    Division of Hospital Medicine, University of California, San Francisco Electronic address
    Am J Med 127:608-15. 2014
  2. pmc Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism
    Patrick P Kneeland
    The University of California, San Francisco Division of Hospital Medicine, San Francisco, CA, USA
    Patient Prefer Adherence 4:51-60. 2010
  3. pmc Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants
    Margaret C Fang
    Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, Box 0131, San Francisco, CA 94143, USA
    Stroke 43:1795-9. 2012
  4. doi request reprint Antithrombotic therapy for the treatment of atrial fibrillation in the elderly
    Margaret C Fang
    Division of Hospital Medicine, University of California at San Francisco, 533 Parnassus Ave, P O Box 0131, San Francisco, CA 94143, USA
    J Interv Card Electrophysiol 25:19-23. 2009
  5. pmc Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication
    Margaret C Fang
    Division of Hospital Medicine, University of California, San Francisco, CA 94143, United States
    Patient Educ Couns 75:403-10. 2009
  6. ncbi request reprint National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation
    Margaret C Fang
    Massachusetts General Hospital, Boston, USA
    Arch Intern Med 164:55-60. 2004
  7. pmc Trends in thrombolytic use for ischemic stroke in the United States
    Margaret C Fang
    Division of Hospital Medicine, The University of California, San Francisco, San Francisco, California 94143, USA
    J Hosp Med 5:406-9. 2010
  8. pmc Warfarin discontinuation after starting warfarin for atrial fibrillation
    Margaret C Fang
    Department of Medicine, University of California, San Francisco, 94143, USA
    Circ Cardiovasc Qual Outcomes 3:624-31. 2010
  9. pmc Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery
    M C Fang
    Division of Hospital Medicine, The University of California San Francisco, CA, USA
    J Thromb Haemost 9:1318-25. 2011
  10. pmc A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    Margaret C Fang
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    J Am Coll Cardiol 58:395-401. 2011

Detail Information

Publications31

  1. pmc Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008
    Margaret C Fang
    Division of Hospital Medicine, University of California, San Francisco Electronic address
    Am J Med 127:608-15. 2014
    ..Stroke is a major cause of morbidity and mortality. We describe trends in the incidence, outcomes, and risk factors for stroke in the US Medicare population from 1988 to 2008...
  2. pmc Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism
    Patrick P Kneeland
    The University of California, San Francisco Division of Hospital Medicine, San Francisco, CA, USA
    Patient Prefer Adherence 4:51-60. 2010
    ....
  3. pmc Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants
    Margaret C Fang
    Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, Box 0131, San Francisco, CA 94143, USA
    Stroke 43:1795-9. 2012
    ..We assessed the impact of anticoagulation on 30-day mortality from ischemic stroke versus ICH in a large community-based cohort of patients with atrial fibrillation...
  4. doi request reprint Antithrombotic therapy for the treatment of atrial fibrillation in the elderly
    Margaret C Fang
    Division of Hospital Medicine, University of California at San Francisco, 533 Parnassus Ave, P O Box 0131, San Francisco, CA 94143, USA
    J Interv Card Electrophysiol 25:19-23. 2009
    ..Although the risk of intracranial hemorrhage is generally quite low, its occurrence is associated with significant mortality and disability, and more effective methods to risk stratify patients for intracranial hemorrhage are needed...
  5. pmc Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication
    Margaret C Fang
    Division of Hospital Medicine, University of California, San Francisco, CA 94143, United States
    Patient Educ Couns 75:403-10. 2009
    ..We assessed the stroke-related health literacy of anticoagulated patients to inform ways in which to improve health communication among people taking warfarin...
  6. ncbi request reprint National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation
    Margaret C Fang
    Massachusetts General Hospital, Boston, USA
    Arch Intern Med 164:55-60. 2004
    ..Atrial fibrillation is the most common cardiac arrhythmia associated with significant medical complications. We examined trends in the medical therapy of atrial fibrillation in the United States from 1991 through 2000...
  7. pmc Trends in thrombolytic use for ischemic stroke in the United States
    Margaret C Fang
    Division of Hospital Medicine, The University of California, San Francisco, San Francisco, California 94143, USA
    J Hosp Med 5:406-9. 2010
    ..Recent guidelines and regulatory agencies have advocated for increased tPA administration in appropriate patients, but it is unclear how many patients actually receive tPA...
  8. pmc Warfarin discontinuation after starting warfarin for atrial fibrillation
    Margaret C Fang
    Department of Medicine, University of California, San Francisco, 94143, USA
    Circ Cardiovasc Qual Outcomes 3:624-31. 2010
    ..The objective of this study was to describe factors associated with warfarin discontinuation in patients newly starting warfarin for atrial fibrillation...
  9. pmc Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery
    M C Fang
    Division of Hospital Medicine, The University of California San Francisco, CA, USA
    J Thromb Haemost 9:1318-25. 2011
    ..The number of spinal fusion operations in the USA is rapidly rising, but little is known about optimal venous thromboembolism prophylaxis after spinal surgery...
  10. pmc A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    Margaret C Fang
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    J Am Coll Cardiol 58:395-401. 2011
    ..The purpose of this study was to develop a risk stratification score to predict warfarin-associated hemorrhage...
  11. pmc Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
    Margaret C Fang
    Department of Medicine, University of California at San Francisco, San Francisco, California, USA
    J Am Coll Cardiol 51:810-5. 2008
    ..We assessed 5 risk stratification schemes for their ability to predict atrial fibrillation (AF)-related thromboembolism in a large community-based cohort...
  12. pmc Death and disability from warfarin-associated intracranial and extracranial hemorrhages
    Margaret C Fang
    The Department of Medicine, Hospitalist Group, University of California, San Francisco, Calif 94143, USA
    Am J Med 120:700-5. 2007
    ..We examined the rates of death and disability resulting from warfarin-associated intracranial and extracranial hemorrhages in a large cohort of patients with atrial fibrillation...
  13. ncbi request reprint Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
    Margaret C Fang
    Division of General Internal Medicine, Hospitalist Group, University of California, San Francisco, San Francisco 94143, USA
    Ann Intern Med 141:745-52. 2004
    ..However, higher intensities increase hemorrhage risk. Optimal use of warfarin for atrial fibrillation requires precise information on the risk for intracranial hemorrhage as a function of patient age and anticoagulation intensity...
  14. ncbi request reprint Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine
    Margaret C Fang
    Division of General Internal Medicine Hospitalist Group, Department of Medicine, University of California, San Francisco, 94143, USA
    Am J Med 117:575-81. 2004
    ..We assessed national trends in the proportion of women among patients seeing female physicians, and compared visit characteristics and preventive services among visits to female and male primary care physicians...
  15. pmc Health literacy and anticoagulation-related outcomes among patients taking warfarin
    Margaret C Fang
    Division of General Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
    J Gen Intern Med 21:841-6. 2006
    ..Little is known about whether health literacy affects anticoagulation-related outcomes...
  16. pmc Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study
    Margaret C Fang
    University of California at San Francisco, 94143, USA
    J Am Geriatr Soc 54:1231-6. 2006
    ..To assess whether older age is independently associated with hemorrhage risk in patients with atrial fibrillation, whether or not they are taking warfarin therapy...
  17. ncbi request reprint Atrial fibrillation in the elderly
    Margaret C Fang
    Division of General Internal Medicine Hospitalist Group, University of California, San Francisco, CA 94143, USA
    Am J Med 120:481-7. 2007
    ..In symptomatic patients who fail pharmacologic therapy, invasive strategies such as AV nodal ablation may help improve quality of life and symptoms, although such strategies do not obviate the need for antithrombotic therapy...
  18. ncbi request reprint Anticoagulation for atrial fibrillation
    Margaret C Fang
    University of California, San Francisco, 533 Parnassus Avenue, Box 0131, San Francisco, CA 94143, USA
    Cardiol Clin 22:47-62. 2004
    ....
  19. pmc Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study
    Margaret C Fang
    University of California, San Francisco, CA 94143, USA
    Circulation 112:1687-91. 2005
    ..We examined data from a large contemporary cohort of AF patients to address this question...
  20. pmc Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study
    Daniel E Singer
    Clinical Epidemiology Unit, General Medicine Division, Massachusetts General Hospital, Boston, MA 02114, USA
    Circ Cardiovasc Qual Outcomes 2:297-304. 2009
    ..0 to 3.0 for preventing ischemic stroke in atrial fibrillation. We assessed whether the INR target should be adjusted based on selected patient characteristics...
  21. pmc The net clinical benefit of warfarin anticoagulation in atrial fibrillation
    Daniel E Singer
    Massachusetts General Hospital, Boston, Massachussetts 02114, USA
    Ann Intern Med 151:297-305. 2009
    ..These guidelines rely on ischemic stroke rates observed in older trials and do not explicitly account for increased risk for hemorrhage...
  22. ncbi request reprint Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    Daniel E Singer
    Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    Chest 133:546S-592S. 2008
    ..However, in patients without contraindications to anticoagulation, we suggest beginning IV heparin or LMWH at presentation (Grade 2C)...
  23. pmc A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score
    Daniel E Singer
    Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    J Am Heart Assoc 2:e000250. 2013
    ....
  24. pmc Long-term survival after ischemic stroke in patients with atrial fibrillation
    Margaret C Fang
    From the Departments of Medicine M C F, A S G and Epidemiology and Biostatistics A S G, University of California, San Francisco Division of Research A S G, N K P, N U, Kaiser Permanente of Northern California, Oakland and Clinical Epidemiology Unit Y C, L H B, D E S, General Medicine Division, Massachusetts General Hospital, Boston
    Neurology 82:1033-7. 2014
    ..While the short-term impact of atrial fibrillation-related stroke has been well studied, surprisingly little is known about its long-term effect on survival...
  25. doi request reprint Atrial fibrillation: stroke prevention in older adults
    Gene R Quinn
    Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    Clin Geriatr Med 28:617-34. 2012
    ..For patients at lower stroke risk, bleeding risk stratification tools can also be used when the benefit of anticoagulant therapy is unclear...
  26. pmc Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients
    John F Mission
    The University of California San Francisco School of Medicine, San Francisco, CA, USA
    J Gen Intern Med 25:321-5. 2010
    ..However, because of the increased risk of deep vein thrombosis with permanent filters, placement of retrievable filters has been recommended. Little is known about the factors associated with planned retrieval of IVC filters...
  27. pmc Assessing bleeding risk in patients taking anticoagulants
    Marwa Shoeb
    Division of Hospital Medicine, University of California, San Francisco, CA 94143, USA
    J Thromb Thrombolysis 35:312-9. 2013
    ..Using risk tools may also help counsel and inform patients about their potential risk for hemorrhage while on anticoagulants, and can identify patients who might benefit from more careful management of anticoagulation...
  28. pmc Trends in catheter ablation for atrial fibrillation in the United States
    Patrick P Kneeland
    Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    J Hosp Med 4:E1-5. 2009
    ..We analyzed data from the National Hospital Discharge Survey (NHDS) to examine trends in the rate of catheter ablation for hospitalized patients with AF over a 15-year period...
  29. doi request reprint Performance of an online translation tool when applied to patient educational material
    Raman R Khanna
    Division of General Internal Medicine, University of California, San Francisco, San Francisco, California 94143 1211, USA
    J Hosp Med 6:519-25. 2011
    ..Online translation tools could fill this gap, but their accuracy is unknown. We evaluated the accuracy of an online translation tool for patient educational material...
  30. ncbi request reprint Cost considerations surrounding current and future anticoagulant therapies
    Margaret C Fang
    Department of Medicine Hospitalist Group, University of California, San Francisco, CA 94143 0131, USA
    Cleve Clin J Med 72:S43-9. 2005
    ..These principles should guide clinicians' choices of anticoagulation strategies...
  31. ncbi request reprint Antithrombotic therapy for stroke prevention in atrial fibrillation
    Alan S Go
    Division of Research, Kaiser Permanente of Northern California, 2000 Broadway St, 3rd Floor, Oakland, CA 94612 2304, USA
    Prog Cardiovasc Dis 48:108-24. 2005
    ....

Research Grants3

  1. Risks of Warfarin for Elders with Atrial Fibrillation
    Margaret Fang; Fiscal Year: 2007
    ..Together, these projects will provide practical experience and form the basis for future studies that seek to improve the safety and use of anticoagulants in the oldest patients with atrial fibrillation. ..
  2. Anticoagulation Treatment and Long-Term Outcomes After Venous Thromboembolism
    Margaret C Fang; Fiscal Year: 2010
    ..This project will evaluate current treatment patterns for VTE, identify risk factors for adverse outcomes, and develop clinically applicable risk-stratification tools to help predict recurrent VTE and major hemorrhagic complications. ..